Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1982 Dec;41(6):604–606. doi: 10.1136/ard.41.6.604

Glycosylated haemoglobin in rheumatoid arthritis.

R M Bernstein, D B Freedman, S P Liyanage, P Dandona
PMCID: PMC1000993  PMID: 7149798

Abstract

Shortened red cell survival has a role in the anaemia of rheumatoid arthritis (RA), but direct measurement of it is difficult. Glycosylated haemoglobin (HbA1) provides an index of red cell life span in normoglycaemic patients, because glycosylation depends on both the concentration of blood glucose and the duration of erythrocyte survival. HbA1 was significantly lower in 30 patients with RA (5.6 +/- 0.7%, mean +/- SD) than in 15 healthy controls (7.3 +/- 0.7%) and 14 patients with osteoarthritis (7.4 +/- 0.7%, p less than 0.001). HbA1 was depressed less in active RA than during remission, which is consistent with diminished red cell production in active RA. These data on HbA1 confirm that shortened red cell survival is common in RA, and point to diminished red cell production in active disease. Determination of HbA1 should prove to be of clinical value in the assessment of normoglycaemic patients with RA but is an inadequate index of glucose homoeostasis in diabetics with RA.

Full text

PDF
605

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brooks A. P., Metcalfe J., Day J. L., Edwards M. S. Iron deficiency and glycosylated haemoglobin A. Lancet. 1980 Jul 19;2(8186):141–141. doi: 10.1016/s0140-6736(80)90019-7. [DOI] [PubMed] [Google Scholar]
  2. Bunn H. F., Gabbay K. H., Gallop P. M. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science. 1978 Apr 7;200(4337):21–27. doi: 10.1126/science.635569. [DOI] [PubMed] [Google Scholar]
  3. Dandona P., Freedman D., Moorhead J. F. Glycosylated haemoglobin in chronic renal failure. Br Med J. 1979 May 5;1(6172):1183–1184. doi: 10.1136/bmj.1.6172.1183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dinant H. J., de Maat C. E. Erythropoiesis and mean red-cell lifespan in normal subjects and in patients with the anaemia of active rheumatoid arthritis. Br J Haematol. 1978 Jul;39(3):437–444. doi: 10.1111/j.1365-2141.1978.tb01114.x. [DOI] [PubMed] [Google Scholar]
  5. RICHMOND J., ALEXANDER W. R., POTTER J. L., DUTHIE J. J. The nature of anaemia in rheumatoid arthritis. V. Red Cell survival measured by radioactive chromium. Ann Rheum Dis. 1961 Jun;20:133–137. doi: 10.1136/ard.20.2.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Saddi R., Wajcman H., Eschwege E., Levy R., Duchateau A. Glycosylated haemoglobin in patients on venesection therapy for haemochromatosis. Lancet. 1980 Jul 19;2(8186):141–142. doi: 10.1016/s0140-6736(80)90020-3. [DOI] [PubMed] [Google Scholar]
  7. Samson D., Halliday D., Gumpel J. M. Role of ineffective erythropoiesis in the anaemia of rheumatoid arthritis. Ann Rheum Dis. 1977 Apr;36(2):181–185. doi: 10.1136/ard.36.2.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Williams B. D., Pussell B. A., Lockwood C. M., Cotton C. Defective reticuloendothelial system function in rheumatoid arthritis. Lancet. 1979 Jun 23;1(8130):1311–1314. doi: 10.1016/s0140-6736(79)91947-0. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES